All Pharma News
Covis granted FDA hearing over premature-birth med Makena

Covis granted FDA hearing over premature-birth med Makena
N. H. Dunn FIERCEPHARMA
21 Aug 2021
Share Share
FDA, unmoved by new meta-analysis, still recommends Makena withdrawal

FDA, unmoved by new meta-analysis, still recommends Makena withdrawal
Kari Oakes RAPS
30 Mar 2021
Share Share
AMAG Pharmaceuticals Files Submission in Response To theFDA’s Notice

AMAG Pharmaceuticals Files Submission in Response To theFDA’s Notice
GLOBENEWSWIRE
14 Dec 2020
Share Share
Covis Group Completes Acquisition of AMAG Pharmaceuticals

Covis Group Completes Acquisition of AMAG Pharmaceuticals
PRNEWSWIRE
16 Nov 2020
Share Share
Covis Group Completes Acquisition of AMAG Pharmaceuticals

Covis Group Completes Acquisition of AMAG Pharmaceuticals
BIOSPACE
16 Nov 2020
Share Share
AMAG Pharmaceuticals Requests Hearing to Maintain Makena®

AMAG Pharmaceuticals Requests Hearing to Maintain Makena®
GLOBENEWSWIRE
14 Oct 2020
Share Share
FDA moves to pull preterm birth drug from market

FDA moves to pull preterm birth drug from market
Kristin Jensen BIOPHARMADIVE
07 Oct 2020
Share Share
FDA seeks withdrawal of Makena, generics from market

FDA seeks withdrawal of Makena, generics from market
M. Mezher RAPS
06 Oct 2020
Share Share
FDA urges removal of Amag drug from market amid $500M acquisition

FDA urges removal of Amag drug from market amid $500M acquisition
Allison DeAngelis BIZJOURNALS
05 Oct 2020
Share Share
Covis Group to acquire AMAG Pharmaceuticals in $647m deal

Covis Group to acquire AMAG Pharmaceuticals in $647m deal
PHARMAFILE
05 Oct 2020
Share Share